---
title: "GHMC: It is expected that the net profit attributable to the parent company for the year 2024 will be revised to between 500 million and 530 million yuan"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/231671238.md"
description: "GHMC announced that in the \"2024 Annual Performance Forecast\" disclosed on January 22, 2025, the company expected the net profit attributable to shareholders of the listed company for 2024 to be between 80 million yuan and 110 million yuan. It has now been revised to a profit of 500 million to 530 million yuan, an increase of 568.16% to 608.24% compared to the same period last year. The company plans to write off other receivables related to the relevant matters that have been on the books for more than three years in 2024 and deduct asset losses, which means re-measuring the deferred tax assets and deferred tax liabilities confirmed as of the end of 2024, resulting in a decrease in the amounts of deferred tax assets and deferred tax liabilities, a reduction in income tax expenses, and a corresponding increase in net profit attributable to shareholders of the listed company of approximately 425 million yuan"
datetime: "2025-03-13T09:49:07.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/231671238.md)
  - [en](https://longbridge.com/en/news/231671238.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/231671238.md)
generator: "portal-rs"
---

# GHMC: It is expected that the net profit attributable to the parent company for the year 2024 will be revised to between 500 million and 530 million yuan

According to a report from Jin10 Data on March 13, Hongmian Co., Ltd. announced that in its "2024 Annual Performance Forecast" disclosed on January 22, 2025, the company expected a net profit attributable to shareholders of the listed company for 2024 to be between 80 million yuan and 110 million yuan. It has now been revised to a profit of 500 million to 530 million yuan, an increase of 568.16% to 608.24% compared to the same period last year. The company plans to write off other receivables related to the relevant matters that have been on the books for more than three years in 2024 and deduct asset losses, which will involve re-measuring the deferred tax assets and deferred tax liabilities confirmed as of the end of 2024, resulting in a decrease in the amounts of deferred tax assets and deferred tax liabilities, a reduction in income tax expenses, and an approximate increase of 425 million yuan in net profit attributable to shareholders of the listed company

### Related Stocks

- [000523.CN](https://longbridge.com/en/quote/000523.CN.md)

## Related News & Research

- [Sopharma management commentary says H1 2026 earnings rise on higher sales, boosted by brands acquired in late 2024](https://longbridge.com/en/news/297315121.md)
- [UK Mortgage Approvals Lowest Since 2024](https://longbridge.com/en/news/297655077.md)
- [BRAIN Biotech cuts FY 2025/26 BRAINBiocatalysts outlook, sees revenue growth below FY 2024/25 level](https://longbridge.com/en/news/297129636.md)
- [SOTL: Record revenue, margin expansion, and innovation drive robust growth and future optimism](https://longbridge.com/en/news/297615048.md)
- [OpenAI's ad business shows blistering growth, hits $1 billion annualized revenue run rate](https://longbridge.com/en/news/297522913.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**